| 2026-08-04 | Press release | Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement with BrainStorm Therapeutics; Initial Parkinson's |
| 2026-08-04 | Press release | Lunai Bioworks (Nasdaq: LNAI) Names 10 Defendants in Naked Short Selling Fraud Suit |
| 2026-06-17 | Press release | LUNAI BIOWORKS: CEO LETTER TO SHAREHOLDERS |
| 2026-05-28 | Press release | Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collabora |
| 2026-05-22 | Press release | Federal Judge Orders Expedited Discovery to Identify 'John Doe' Defendants 'Naked' Short-Sellers of Lunai Common Stock |
| 2026-05-20 | Press release | LUNAI BIOWORKS, INC. ANNOUNCES REVERSE STOCK SPLIT |
| 2026-05-04 | Press release | Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP |
| 2026-04-15 | Press release | Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships |
| 2026-04-07 | Press release | Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI |
| 2026-03-26 | Press release | Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Al |
| 2026-03-19 | Press release | Lunai Bioworks (NASDAQ: LNAI) Launches National Chemical Defense Consortium Targeting $400M-$1.2B U.S. Countermeasure Pr |
| 2026-02-19 | Press release | Lunai Bioworks (NASDAQ: LNAI) Locks Down Core AI Architecture with U.S. Patent Enabling Precision Disease Subtyping |
| Press release | Read More |
| 2026-02-09 | Press release | Lunai Bioworks (NASDAQ: LNAI) Launches AI Oncology Pilot with Clinical-Stage Partner to Analyze Randomized Phase 2 Metas |
| 2026-02-09 | Press release | Lunai Bioworks, Inc. Issues Letter to Shareholders |
| 2026-01-27 | Press release | Lunai Bioworks (NASDAQ: LNAI) Launches Sentinel, an AI Safeguard to Block Large Language Models from Generating Novel Ch |
| 2026-01-26 | Press release | Lunai Bioworks (NASDAQ: LNAI) Expands NIH-Funded AI Program into Commercial Alcohol Use Disorder Drug Discovery |